Sarosiek J, Slomiany B L, Slomiany A, Gabryelewicz A
Scand J Gastroenterol. 1984 Jul;19(5):650-4.
The glyceroglucolipids content of basal and pentagastrin-stimulated gastric secretion was measured in male patients with gastric (12) and duodenal (12) ulcer. Six patients in each group received twice daily for a period of 4 weeks 150 mg of ranitidine, whereas the other patients received placebo. The glyceroglucolipids output in the basal secretion of patients with gastric and duodenal ulcer before treatment was similar and increased 2.7-fold after pentagastrin stimulation. In all patients treated with ranitidine, the mean output of glyceroglucolipids after pentagastrin stimulation increased from 1.38 to 2.05 mumol/h (P less than 0.05). This increase, however, was more pronounced in the duodenal ulcer group than in the gastric ulcer patients. No change in glyceroglucolipids output was noted in the patients treated with placebo. The ratio of glyceroglucolipids to HCl increased significantly (P less than 0.02) only in the ranitidine-treated patients.
对患有胃溃疡(12例)和十二指肠溃疡(12例)的男性患者,测定了基础胃酸分泌和五肽胃泌素刺激的胃酸分泌中的甘油糖脂含量。每组6例患者每日两次服用150毫克雷尼替丁,持续4周,而其他患者服用安慰剂。治疗前,胃溃疡和十二指肠溃疡患者基础分泌中的甘油糖脂排出量相似,五肽胃泌素刺激后增加了2.7倍。在所有接受雷尼替丁治疗的患者中,五肽胃泌素刺激后的甘油糖脂平均排出量从1.38微摩尔/小时增加到2.05微摩尔/小时(P<0.05)。然而,这种增加在十二指肠溃疡组比胃溃疡患者中更明显。服用安慰剂的患者甘油糖脂排出量无变化。仅在接受雷尼替丁治疗的患者中,甘油糖脂与盐酸的比率显著增加(P<0.02)。